We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
TC Energy
TRP
$63.6B
| $10.4M | 0.04% |
194,697
+7,000
| +4% | +$359K |
|
427
Credicorp
BAP
$29.6B
| $10.4M | 0.04% |
48,593
+2,732
| +6% | +$572K |
|
428
Assured Guaranty
AGO
$3.14B
| $10.3M | 0.04% |
211,100
-2,100
| -1% | -$100K |
|
429
Twilio
TWLO
$37.2B
| $10.3M | 0.04% |
104,756
-11,347
| -10% | -$1.16M |
|
430
Humana
HUM
$47.6B
| $10.2M | 0.04% |
27,953
+9,344
| +50% | +$2.96M |
|
431
Sabre
SABR
$843M
| $10.2M | 0.04% |
456,100
-17,700
| -4% | -$392K |
|
432
KLA
KLAC
$220B
| $10.2M | 0.04% |
570,510
+517,090
| +968% | +$8.67M |
|
433
NCR Voyix
VYX
$1.04B
| $10.2M | 0.04% |
470,744
-1,304
| -0.3% | -$25.4K |
|
|
WCN
434
Waste Connections
WCN
$40.1B
| $10.1M | 0.04% |
111,784
-8,682
| -7% | -$788K |
|
435
SolarEdge
SEDG
$2.17B
| $10.1M | 0.04% |
106,600
+85,800
| +413% | +$7.34M |
|
436
CSX Corp
CSX
$90.1B
| $10.1M | 0.04% |
417,783
-1,218
| -0.3% | -$28.8K |
|
437
Universal Display
OLED
$3.58B
| $10M | 0.04% |
48,600
-1,400
| -3% | -$265K |
|
438
Icon
ICLR
$13.3B
| $9.95M | 0.04% |
57,753
| – | – |
|
439
Cooper Companies
COO
$10.1B
| $9.91M | 0.04% |
123,384
-176,456
| -59% | -$13.3M |
|
440
Brown & Brown
BRO
$22.5B
| $9.84M | 0.04% |
249,300
| – | – |
|
|
ARNA
441
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $9.8M | 0.04% |
215,835
+4,984
| +2% | +$236K |
|
442
Zai Lab
ZLAB
$2.78B
| $9.73M | 0.04% |
233,928
+57,691
| +33% | +$2.13M |
|
443
Celanese
CE
$5.18B
| $9.7M | 0.04% |
78,743
-833
| -1% | -$103K |
|
444
RingCentral
RNG
$6.05B
| $9.66M | 0.04% |
57,300
-15,666
| -21% | -$2.58M |
|
|
TPTX
445
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.5M | 0.04% |
+152,569
| New | +$7.26M |
|
446
argenx
ARGX
$61.3B
| $9.48M | 0.04% |
59,084
-20,880
| -26% | -$2.82M |
|
447
Ziff Davis
ZD
$2.03B
| $9.47M | 0.04% |
116,265
-2,530
| -2% | -$209K |
|
448
Strategic Education
STRA
$1.85B
| $9.42M | 0.04% |
59,283
+1,047
| +2% | +$145K |
|
449
Genpact
G
$6.03B
| $9.36M | 0.04% |
222,000
-12,300
| -5% | -$492K |
|
450
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
| $9.32M | 0.04% |
289,644
+24,091
| +9% | +$715K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.